H S Garewal

4.4k total citations
56 papers, 3.5k citations indexed

About

H S Garewal is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, H S Garewal has authored 56 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Surgery, 16 papers in Pulmonary and Respiratory Medicine and 16 papers in Oncology. Recurrent topics in H S Garewal's work include Gastric Cancer Management and Outcomes (11 papers), Esophageal Cancer Research and Treatment (10 papers) and Helicobacter pylori-related gastroenterology studies (5 papers). H S Garewal is often cited by papers focused on Gastric Cancer Management and Outcomes (11 papers), Esophageal Cancer Research and Treatment (10 papers) and Helicobacter pylori-related gastroenterology studies (5 papers). H S Garewal collaborates with scholars based in United States, Canada and Mexico. H S Garewal's co-authors include Richard E. Sampliner, M. Brian Fennerty, Lee J. Hixson, Carol Bernstein, Harris Bernstein, C. M. Payne, Kateřina Dvořáková, D L McGee, Ronnie Fass and Isaac Malagon and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

H S Garewal

56 papers receiving 3.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H S Garewal United States 31 1.3k 1.2k 1.0k 851 578 56 3.5k
Harinder S. Garewal United States 37 1.5k 1.1× 961 0.8× 1.0k 1.0× 1.1k 1.3× 459 0.8× 120 3.8k
Young‐Eun Joo South Korea 37 1.9k 1.5× 1.2k 1.0× 1.3k 1.3× 1.2k 1.4× 859 1.5× 279 4.8k
Toshio Takahashi Japan 32 878 0.7× 828 0.7× 886 0.9× 834 1.0× 267 0.5× 144 3.3k
Katsunori Saigenji Japan 32 1.4k 1.1× 1.8k 1.5× 1.4k 1.4× 589 0.7× 679 1.2× 209 4.6k
Lars‐Erik Hansson Sweden 30 2.4k 1.8× 811 0.7× 1.5k 1.5× 539 0.6× 441 0.8× 48 3.8k
P Corréa United States 46 4.5k 3.4× 1.3k 1.1× 2.4k 2.4× 1.2k 1.4× 830 1.4× 135 7.7k
Jerome J. DeCosse United States 39 1.6k 1.2× 1.7k 1.5× 1.1k 1.1× 665 0.8× 264 0.5× 115 4.8k
Arne Bakka Norway 34 823 0.6× 1.6k 1.4× 374 0.4× 580 0.7× 131 0.2× 81 3.8k
Eiji Uchida Japan 32 1.5k 1.1× 1.5k 1.3× 733 0.7× 1.2k 1.4× 134 0.2× 282 4.0k
Soo Jung Park South Korea 34 1.1k 0.8× 868 0.7× 555 0.5× 858 1.0× 266 0.5× 201 3.6k

Countries citing papers authored by H S Garewal

Since Specialization
Citations

This map shows the geographic impact of H S Garewal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H S Garewal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H S Garewal more than expected).

Fields of papers citing papers by H S Garewal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H S Garewal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H S Garewal. The network helps show where H S Garewal may publish in the future.

Co-authorship network of co-authors of H S Garewal

This figure shows the co-authorship network connecting the top 25 collaborators of H S Garewal. A scholar is included among the top collaborators of H S Garewal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H S Garewal. H S Garewal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Payne, C. M., Craig Weber, Katerina Dvorak, et al.. (2006). Deoxycholate induces mitochondrial oxidative stress and activates NF- B through multiple mechanisms in HCT-116 colon epithelial cells. Carcinogenesis. 28(1). 215–222. 136 indexed citations
2.
Dickman, Ram, et al.. (2006). Correlation of gastroesophageal reflux disease symptoms characteristics with long-segment Barrett’s esophagus. Diseases of the Esophagus. 19(5). 360–365. 13 indexed citations
3.
Dvorak, Katerina, Melissa Chavarria, Laura B. Ramsey, et al.. (2006). Bile acids in combination with low pH induce oxidative stress and oxidative DNA damage: relevance to the pathogenesis of Barrett’s oesophagus. Gut. 56(6). 763–771. 196 indexed citations
4.
Payne, C. M., Cara L Crowley-Weber, Katerina Dvorak, et al.. (2005). Mitochondrial perturbation attenuates bile acid-induced cytotoxicity. Cell Biology and Toxicology. 21(5-6). 215–231. 28 indexed citations
5.
Bernstein, Harris, Carol Bernstein, C. M. Payne, Kateřina Dvořáková, & H S Garewal. (2004). Bile acids as carcinogens in human gastrointestinal cancers. Mutation Research/Reviews in Mutation Research. 589(1). 47–65. 463 indexed citations
6.
Payne, C. M., Cara L Crowley-Weber, Harris Bernstein, et al.. (2003). Caspase-6 mediated cleavage of guanylate cyclase alpha 1 during deoxycholate-induced apoptosis: Protective role of the nitric oxide signaling module. Cell Biology and Toxicology. 19(6). 373–392. 18 indexed citations
7.
Garewal, H S, et al.. (2001). Short segment Barrett's esophagus: relationship of age with extent of intestinal metaplasia. The American Journal of Gastroenterology. 96(11). 3084–3088. 11 indexed citations
8.
Navari, Rudolph M., Stefan Madajewicz, N. Anderson, et al.. (1995). Oral ondansetron for the control of cisplatin-induced delayed emesis: a large, multicenter, double-blind, randomized comparative trial of ondansetron versus placebo.. Journal of Clinical Oncology. 13(9). 2408–2416. 68 indexed citations
9.
Habib, Michael P., et al.. (1995). Cigarette Smoking and Ethane Exhalation in Humans. American Journal of Respiratory and Critical Care Medicine. 151(5). 1368–1372. 46 indexed citations
10.
Nelson, Mark A., et al.. (1995). Analysis of K-Ras Gene Mutations in Malignant and Nonmalignant Endobronchial Tissue Obtained by Fiberoptic Bronchoscopy. American Journal of Respiratory and Critical Care Medicine. 152(4). 1374–1378. 20 indexed citations
11.
Garewal, H S & A. T. Diplock. (1995). How ???Safe??? Are Antioxidant Vitamins?. Drug Safety. 13(1). 8–14. 18 indexed citations
12.
Lazarus, Philip, et al.. (1995). A low incidence of p53 mutations in pre‐malignant lesions of the oral cavity from non‐tobacco users. International Journal of Cancer. 60(4). 458–463. 39 indexed citations
13.
Garewal, H S. (1995). Antioxidants in oral cancer prevention. American Journal of Clinical Nutrition. 62(6). 1410S–1416S. 46 indexed citations
14.
Garewal, H S & Stimson Schantz. (1995). Emerging Role of  -Carotene and Antioxidant Nutrients in Prevention of Oral Cancer. Archives of Otolaryngology - Head and Neck Surgery. 121(2). 141–144. 34 indexed citations
15.
Ritenbaugh, Cheryl, et al.. (1995). Risk factors for Barrettʼs oesophagus. European Journal of Cancer Prevention. 4(6). 459–468. 20 indexed citations
16.
Squillace, Susan Pollart, Philip E. Jaffe, M. Brian Fennerty, et al.. (1994). A normal initial colonoscopy after age 50 does not predict a polyp-free status for life.. PubMed. 89(8). 1156–9. 17 indexed citations
17.
Garewal, H S & F. L. Meyskens. (1991). Beta-Carotene Didn't Prevent Cancer: What's Up Doc?. JNCI Journal of the National Cancer Institute. 83(15). 1111–1111. 1 indexed citations
18.
Hixson, Lee J., M. Brian Fennerty, Richard E. Sampliner, & H S Garewal. (1991). Prospective blinded trial of the colonoscopic miss-rate of large colorectal polyps. Gastrointestinal Endoscopy. 37(2). 125–127. 217 indexed citations
19.
Garewal, H S, FL Meyskens, D. S. Reeves, et al.. (1990). Response of oral leukoplakia to beta-carotene.. Journal of Clinical Oncology. 8(10). 1715–1720. 130 indexed citations
20.
Garewal, H S, Brian G.M. Durie, Robert A. Kyle, et al.. (1984). Serum beta 2-microglobulin in the initial staging and subsequent monitoring of monoclonal plasma cell disorders.. Journal of Clinical Oncology. 2(1). 51–57. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026